News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorite Drugs For Lung Cancer – Even Better Ones Are Yet to Come
Yakup Ergün/obdh.com.tr
Jun 19, 2025, 11:53

Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorite Drugs For Lung Cancer – Even Better Ones Are Yet to Come

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared an article on X:

“The next generation of immunotherapies for lung cancers
Although there are many drugs currently in development, my current favorites are ivonescimab (PD-1 × VEGF) and tarlatamab (DLL3 × CD3).
Even better ones are yet to come.”
ivonescimab

Title: The next generation of immunotherapies for lung cancers

Authors: Shen Zhao, Hongyun Zhao, Weiwei Yang, Li Zhang

Read Full Article.

Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorite Drugs For Lung Cancer - Even Better Ones Are Yet to Come

More posts featuring Yakup Ergün.

cancer Hongyun Zhao Li Zhang lung cancers OncoDaily Oncology Shen Zhao Weiwei Yang
Special Coverage
Blog
Jul 9, 2025, 14:02
UICC and ISOPP Call for Better Quality and Safety at Every Level of the Supply Chain to Protect Patients
Blog
Jul 9, 2025, 13:59
Integrating Cervical Cancer Prevention into HIV Programmes: Francophone Africa Workshop in Abidjan - UICC
Blog
Jul 9, 2025, 13:49
Strengthen Your Skills in Delivering Precision NSCLC Care to Your Patients - LUNGevity Foundation
Blog
Jul 9, 2025, 13:33
Oncogene Cancer Research Donates £10,425 to The Institute of Cancer Research to Support Lung Cancer Research
Blog
Jul 9, 2025, 13:19
Francisco J. Esteva: Why I Launched a Channel Focused on Evidence-Based Answers for Anyone Navigating Cancer
Positive
Jul 9, 2025, 13:08
Dana-Farber's New Cancer Hospital will Strengthen Boston’s Position as a Global Leader in Oncology
Opinion
Jul 9, 2025, 11:58
Geography is a Critical Cancer Risk Factor Shaped by Environment, Genetics, and Lifelong Exposures - Jarurat Care
Blog
Jul 9, 2025, 11:56
The SIOG 2025 Scientific Programme is Live
Blog
Jul 9, 2025, 11:26
Don't Miss Out the Upcoming 2nd National Cancer Summit - National Cancer Institute of Kenya
Blog
Jul 9, 2025, 11:10
Hamza Hashmi: ASCO 2025 Summary - Best of Myeloma-Key Trials and Clinical Insights
Blog
Jul 9, 2025, 11:03
How Are New Treatment Pathways Reshaping the Future of Gastric and Liver Cancer Care? - APGCS
Blog
Jul 9, 2025, 10:38
Guillermo Chantada Delivers Keynote on Childhood Cancer Strategy in Latin America